Skip to main content
Health solutions

Mental & behavioural health

The industry experts in mental and behavioural health

Overview

Milliman mental & behavioural health solutions

Mental health parity compliance

Mental health parity compliance

Insight

Milliman mental & behavioural health insight

White Paper

Impact of Mental Health Parity and Addiction Equity Act

What has happened to utilization and costs for mental health and substance use disorder benefits as the mental health parity laws and associated rules were slowly rolled out?

White Paper

Institution for Mental Disease (IMD) as an "in lieu of" service

Beyond the impact of the final rule, IMDs will continue to be a topic of interest to state policy makers as they bolster the continuum of behavioral health and substance use disorder services.

White Paper

Costs and comorbidities of opioid use disorder

This study assesses the prevalence and costs associated with comorbid chronic medical conditions among individuals with diagnosed opioid use disorder (OUD) and opioid super-users without diagnosed OUD.

Article

Transgender healthcare coverage: Prevalence, recent trends, and considerations for payers

A discussion of trends, including recent federal and state laws affecting health insurance benefits for transgender individuals and health insurance clinical coverage policies related to gender reassignment surgery.

White Paper

Opioid prescription drug patterns in diagnosed and non-diagnosed opioid use disorder populations

This paper presents a comparison of opioid prescription drug patterns among diagnosed and non-diagnosed opioid use disorder populations.

White Paper

Opioid use disorder in the U.S.: Diagnosed prevalence by payer, age, sex, and state

Over 25 million American adults report suffering from daily chronic pain. The increasing use of opioids in recent years has taken a human toll, leading to a rising number of overdose deaths and diagnoses of opioid use disorder.

White Paper

Opioid use disorder: Costs, utilization, and comorbidities

Many patients with opioid use disorder have complex healthcare needs, contributing to their significant healthcare costs.

White Paper

Financial sustainability of an integrated medical-behavioral primary care practice

The state of Colorado has implemented behavioral healthcare in primary medical care settings under a Centers for Medicare and Medicaid Services State Innovation Model Award.

White Paper

Nonquantitative treatment limitations in the spotlight

Nonquantitative treatment limitations continue to be a source of difficulty for many health plans in attaining compliance with the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008.

White Paper

The final rules for the Mental Health Parity and Addiction Equity Act of 2008

Final rules clarify how to comply with provisions of the Mental Health Parity and Addiction Equity Act of 2008.

Podcast

Critical Point Episode 7: Diagnosing and predicting opioid use disorder

Stoddard Davenport and Joseph Boschert discuss their latest research on opioid use in the United States, including underdiagnoses and how advanced analytics can help predict whether a patient may develop opioid use disorder.

Contact us